ISAP Endorses Moderate Sedation Training Program for Computer Assisted Personalized Sedation System
On May 3, 2013, Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for the SEDASYS® System, the first computer-assisted personalized sedation (CAPS) system. This system provides moderate sedation for ASA physical status I and II patients, 18 years old undergoing colonoscopy and esophagogastroduodenoscopy (EGD) procedures. Consistent with its mission of fostering and encouraging research, education, and scientific progress in anaesthetic pharmacology, the International Society for Anaesthetic Pharmacology (ISAP) is pleased to provide independent third party development oversight and endorsement of moderate sedation and airway management training for non-anesthesia professionals who administer propofol using a CAPS system. For more information on this important development view this full statement CLICK HERE.
The International Society for Anaesthetic Pharmacology (ISAP) is a nonprofit organization with an international membership, which is dedicated to teaching and research about clinical pharmacology in anesthesia, with particular reference to anesthetic drugs.